Cargando…
COVID-19 Associated Pulmonary Aspergillosis in Patients on Extracorporeal Membrane Oxygenation Treatment—A Retrospective Study
Background: The incidence and outcome of pulmonary aspergillosis in coronavirus disease (COVID-19) patients on extracorporeal membrane oxygenation (ECMO) are unknown and have not been fully addressed. We investigated the incidence, risk factors and outcome of pulmonary aspergillosis in COVID-19 ECMO...
Autores principales: | Nuh, Ali, Ramadan, Newara, Nwankwo, Lisa, Donovan, Jackie, Patel, Brijesh, Shah, Anand, Desai, Sujal R., Armstrong-James, Darius |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146650/ https://www.ncbi.nlm.nih.gov/pubmed/37108853 http://dx.doi.org/10.3390/jof9040398 |
Ejemplares similares
-
Sputum Galactomannan Has Utility in the Diagnosis of Chronic Pulmonary Aspergillosis
por: Nuh, Ali, et al.
Publicado: (2022) -
Experience of Isavuconazole as a Salvage Therapy in Chronic Pulmonary Fungal Disease
por: Nwankwo, Lisa, et al.
Publicado: (2022) -
P249 Predictors of adverse outcome in sarcoidosis complicated by chronic pulmonary aspergillosis
por: Nwankwo, Lisa, et al.
Publicado: (2022) -
P435 Evaluation of remote triazole capillary blood testing to facilitate remote therapeutic drug monitoring (TDM): A validation study
por: Nwankwo, Lisa, et al.
Publicado: (2022) -
Successful long-term extracorporeal membrane oxygenation for invasive pulmonary aspergillosis: a case report
por: Tanaka, Hiroyuki, et al.
Publicado: (2017)